Latest Posts
About This Stock
More About This Stock
Read
Premarket Biotech Digest – RDHL Initiates Two Products. BMY Starts Recall, PULM Inks New Deal
Article By:
KKD Healthcare Analytics
Wednesday, June 14, 2017 9:07 AM EDT
RedHill Biopharma stock perked up as the company announced starting two GI-focused products in the U.S. Aptose Biosciences stock is on rally as the company announced updates for its pipeline candidates CG'806 and APTO-253.